VIROPHARMA INCORPORATED VPHM (NASDAQ) $ 10.99 Change: +0.13 +1.18% | Volume: 458,612
Sponsored by Click here!

VIROPHARMA - Fundamental Profile

Company Information

Ticker Symbol: VPHM
Exchange: NASD
Contact Info: 397 Eagleview Boulevard Exton PA 19341 610 458-7300
CEO/President: Michel de Rosen
Industry: Medical - Drugs / Standard Industry Code: 2834
Description: VIROPHARMA is a leader in RNA virology and RNA antiviral drug discovery and development. The company is committed to the commercialization, development and discovery of antiviral pharmaceuticals. The company focuses on drug development and discovery activities for viral diseases including viral meningitis, viral respiratory infection, pneumonia, hepatitis C and influenza. Each year, a majority of the world\'s population is afflicted by at least one of these diseases, and antiviral therapies are either inadequate or do not exist.

Share Information

Shares Outstanding: 69,960 (000) Market Value: 904,140 ($000)
Percentage of Inst.Shareholders: 88.44% Number of Inst.Shareholders: 4.20%
Last Quarter Sales: 65.91 ($Mil.) Last Quarter Net Income: 27.08 ($Mil.)
Last Quarter EPS: 0.33 P/E Ratio: 10
Most Recent Earnings: 0.33 on 10/29/08 Earnings Per Share: 1.10
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -26.50 16.62
JOHNSON AND JOH -16.70 57.32
BRISTOL MYERS S -15.10 21.70
SCHERING PLOUGH -37.70 16.50
MERCK CO INC -54.40 26.46